Patients with heterozygous mutations in JUP have been diagnosed with HCM [22,23], and reduced cardiac DSG2 levels appear to be specifically associated with arrhythmogenic right ventricular cardiomyopathy (ARVC) [24]. This evidence concerns the gene DSG2 and Arrhythmogenic right ventricular dysplasia.